Clariant AG
CLN.SW · SIX
Company research
Clariant AG (CLN.SW) is a Switzerland-based global leader in specialty chemicals, formally established in 1995 as a spin-off from Sandoz and headquartered in Muttenz, Switzerland. The company operates through three core business units — Care Chemicals, Catalysts, and Adsorbents & Additives — serving a broad range of end markets including personal care, home care, agriculture, automotive, construction, petrochemicals, and mining across 36 countries. With a workforce of approximately 10,281 employees and full-year 2025 sales of CHF 3.915 billion from continuing operations, Clariant delivers innovative and sustainable chemical solutions underpinned by its corporate purpose of "Greater chemistry – between people and planet." Listed on the SIX Swiss Exchange since 1995 under the ticker CLN, the company carries a market capitalisation of approximately CHF 2.5 billion and is led by Chief Executive Officer Conrad Keijzer.
Research reports
Comprehensive, multi‑section fundamental report positioning Clariant as a structurally improving specialty chemicals turnaround with sustainability‑led growth, expanding margins, deleveraging catalysts, and asymmetric five‑year upside, including a probability‑weighted CHF 19.66 5‑year target price and detailed discussion of segment dynamics, cost‑saving programs, valuation scenarios, and execution, geopolitical, regulatory, and raw‑material risks.
Simply Wall St · February 12, 2026Clariant (CLN) Stock AnalysisData‑rich fundamental analysis summarizing Clariant’s business model, geographic and segment mix, valuation and quality “Snowflake” scores, earnings, margins, debt profile, volatility, and analyst coverage, presenting a balanced view of moderate valuation, mixed past performance, and average financial health without an explicit rating tilt, making the overall stance effectively neutral.